Sun Pharma to acquire Japanâs Pola Pharma for $1 million
India's largest drugmaker Sun Pharma on Monday said it will buy Japan's Pola Pharma for around $1 million (â¹7 crore). The Japanese drugmaker specializes in dermatology products and Sun Pharma aims to strengthen its global presence in dermatology sector with this acquisition. The Dilip Shanghvi-led firm entered Japan market in 2016 with the acquisition of 14 brands from Switzerland-based Novartis.